China Oral Industry Group Holdings Limited (“China Oral Industry”) has filed its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stable capital and share metrics across the month. The disclosure was submitted to Hong Kong Exchanges and Clearing Limited on 2 July 2026.

Authorised Share Capital • Authorised capital held steady at 5.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 50.00 million. • No authorised share increase or reduction was recorded during June.

Issued Share Capital & Public Float • Issued shares (excluding treasury shares) remained unchanged at 1.64 billion. • The company held no treasury shares, leaving total issued shares likewise at 1.64 billion. • China Oral Industry confirmed compliance with the Stock Exchange’s minimum public-float requirement of 25%.

Share Option Position • 2017 Share Option Scheme: 80.00 million options outstanding; no exercises occurred in June. • 2025 Share Option Scheme: No options outstanding or exercised; the scheme retains capacity for up to 136.80 million new shares. • No option exercises took place, and the company raised no funds from option conversions during the month.

Other Securities • The company reported no warrants, convertible securities, or other equity-linked instruments outstanding or issued. • There were no repurchases, cancellations, or transfers involving treasury shares.

Administration • The monthly return was signed by Ms. Chan Lok Yin, Secretary, affirming the accuracy of disclosures and sufficiency of public float as of 30 June 2026.